Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device

Go back to Femasys Secures U.S. FDA Clearance for Next-Generation FemVue Diagnostic Device
(NASDAQ: FEMY) Delayed: 3.99 +0.14 (3.64%)
Previous Close $3.85    52 Week High
Open $3.88    52 Week Low
Day High $4.07    P/E N/A 
Day Low $3.88    EPS
Volume 27,172